Literature DB >> 11929825

Toward synthetic combinatorial peptide libraries in positional scanning format (PS-SCL)-based identification of CD8+ Tumor-reactive T-Cell Ligands: a comparative analysis of PS-SCL recognition by a single tumor-reactive CD8+ cytolytic T-lymphocyte clone.

Verena Rubio-Godoy1, Clemencia Pinilla, Valerie Dutoit, Eva Borras, Richard Simon, Yingdong Zhao, Jean-Charles Cerottini, Pedro Romero, Richard Houghten, Danila Valmori.   

Abstract

The use of synthetic combinatorial peptide libraries in positional scanning format (PS-SCL) has emerged recently as an alternative approach for the identification of peptides recognized by T lymphocytes. The choice of both the PS-SCL used for screening experiments and the method used for data analysis are crucial for implementing this approach. With this aim, we tested the recognition of different PS-SCL by a tyrosinase 368-376-specific CTL clone and analyzed the data obtained with a recently developed biometric data analysis based on a model of independent and additive contribution of individual amino acids to peptide antigen recognition. Mixtures defined with amino acids present at the corresponding positions in the native sequence were among the most active for all of the libraries. Somewhat surprisingly, a higher number of native amino acids were identifiable by using amidated COOH-terminal rather than free COOH-terminal PS-SCL. Also, our data clearly indicate that when using PS-SCL longer than optimal, frame shifts occur frequently and should be taken into account. Biometric analysis of the data obtained with the amidated COOH-terminal nonapeptide library allowed the identification of the native ligand as the sequence with the highest score in a public human protein database. However, the adequacy of the PS-SCL data for the identification for the peptide ligand varied depending on the PS-SCL used. Altogether these results provide insight into the potential of PS-SCL for the identification of CTL-defined tumor-derived antigenic sequences and may significantly implement our ability to interpret the results of these analyses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929825

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses.

Authors:  C Siddiq Abdul-Alim; Yongqing Li; Cassian Yee
Journal:  J Immunol       Date:  2010-05-07       Impact factor: 5.422

Review 2.  Cross-reactivity of T cells and its role in the immune system.

Authors:  Galina Petrova; Andrea Ferrante; Jack Gorski
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

3.  Identification of B cell and T cell epitopes using synthetic peptide combinatorial libraries.

Authors:  Clemencia Pinilla; Jon R Appel; Valeria Judkowski; Richard A Houghten
Journal:  Curr Protoc Immunol       Date:  2012-11

4.  Prediction of cross-recognition of peptide-HLA A2 by Melan-A-specific cytotoxic T lymphocytes using three-dimensional quantitative structure-activity relationships.

Authors:  Theres Fagerberg; Vincent Zoete; Sebastien Viatte; Petra Baumgaertner; Pedro M Alves; Pedro Romero; Daniel E Speiser; Olivier Michielin
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.